Analysis of reported SCO2 gene mutations affecting cytochrome c oxidase activity in various diseases
Radhika Chadha1, Ritika Shah2, Shalini Mani2
1International Centre for Genetic Engineering and Biotechnology, New Delhi.
Abstract:
A large number of mutations have been reported in SCO2 (synthesis of cytochrome c oxidase) gene in association with COX deficiency reported in different diseases such as cardioencephalomyopathy, cardiomyopathy and Leigh syndrome. However, very few of these mutations have been functionally analyzed.SCO2 gene encodes for an essential assembly factor for the formation of cytochrome c oxidase (COX). It is a nuclear encoded protein that helps in transfer of copper ions to COX. This study is an attempt to understand the possible effect of these mutations on the structure and function of SCO2 protein, by using different in silico tools. As per Human Gene Mutation Database, total 11 non synonymous variations have been reported in SCO2 gene. Among these 11 variations, only E140K and R171W are functionally proven to cause COX deficiency. They have been used as controls in this study. The remaining variations were further analyzed using ClustalW, SIFT, PolyPhen-2, GOR4, MuPro and Panther softwares. As compared to the results of the controls, most of these variations were predicted to affect the structure of SCO2 protein and hence, may cause COX dysfunction. Thus, we hypothesize that these variations have the potential to result in a disease phenotype and should be investigated by subsequent functional analyses. This will help in an appropriate diagnosis and management of the wide spectrum of COX deficiency diseases.
Insights
Most SCO2 gene mutations linked to cytochrome c oxidase (COX) deficiency may impact protein structure and function. This study used in silico analysis to predict the effects of these mutations, aiding in diagnosing COX deficiency diseases.
Area of Science:
- Molecular Biology
- Genetics
- Computational Biology
Background:
- Mutations in the SCO2 (synthesis of cytochrome c oxidase) gene are associated with COX deficiency disorders like cardioencephalomyopathy, cardiomyopathy, and Leigh syndrome.
- While numerous SCO2 mutations exist, few have undergone functional analysis, limiting understanding of their pathogenic mechanisms.
- SCO2 encodes a crucial assembly factor for cytochrome c oxidase (COX), essential for cellular respiration via copper ion transfer.
Purpose of the Study:
- To investigate the potential structural and functional impacts of reported SCO2 gene mutations using in silico tools.
- To evaluate whether uncharacterized SCO2 variations may contribute to COX deficiency phenotypes.
Main Methods:
- Utilized in silico analysis with tools including ClustalW, SIFT, PolyPhen-2, GOR4, MuPro, and Panther.
- Analyzed 11 non-synonymous SCO2 variations reported in the Human Gene Mutation Database.
- Used functionally validated mutations (E140K, R171W) as controls for comparison.
Main Results:
- In silico analysis predicted that most of the studied SCO2 variations likely affect protein structure.
- These structural alterations suggest a potential to impair SCO2 function and lead to COX dysfunction.
- Results indicate a correlation between predicted structural changes and the potential for disease manifestation.
Conclusions:
- The study hypothesizes that numerous uncharacterized SCO2 mutations can potentially cause disease by affecting protein structure and function.
- Further functional analyses are recommended to validate these in silico predictions.
- This research could improve the diagnosis and management of diverse COX deficiency diseases.
More Related Videos
09:53Author Spotlight: Advancing Techniques and Discoveries in Protein Synthesis and Assembly Through Innovative Mitochondrial Research
Published on: June 7, 2024
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Single Nucleotide Polymorphisms-SNPs
